Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2017
Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical ImplicationSeongyeol Park, Seunggyun Ha, Hyun Woo Kwon, et al.
BMC Pediatrics|October 16, 2021
Severe protein C deficiency in a newborn caused by a homozygous pathogenic variant in the PROC gene: a case reportUisook Song, Young Hye Ryu, Kiteak Hong, et al.
Lung Cancer (Amsterdam, Netherlands)|January 22, 2016
MET amplification, protein expression, and mutations in pulmonary adenocarcinomaSeongyeol Park, Jaemoon Koh, Dong-Wan Kim, et al.
Nature|January 8, 2025
Complex rearrangements fuel ER<sup>+</sup> and HER2<sup>+</sup> breast tumoursKathleen E Houlahan, Lise Mangiante, Cristina Sotomayor-Vivas, et al.
Cancer Biomarkers : Section a of Disease Markers|April 11, 2016
Pretreatment albumin-to-globulin ratio as a predictive marker for tyrosine kinase inhibitor in non-small cell lung cancerSehhoon Park, Seongyeol Park, Se-Hoon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 9, 2021
Acquired Resistance to Third-Generation EGFR Tyrosine Kinase Inhibitors in Patients With De Novo EGFR<sup>T790M</sup>-Mutant NSCLCHa-Ram Park, Tae Min Kim, Yusoo Lee, et al.
Tissue Engineering and Regenerative Medicine|April 19, 2022
Asymmetric Contribution of Blastomere Lineages of First Division of the Zygote to Entire Human Body Using Post-Zygotic VariantsSeong Gyu Kwon, Geon Hue Bae, June Hyug Choi, et al.
Cancer Research and Treatment|July 22, 2015
VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic CarcinomaSeongyeol Park, Soo Jeong Nam, Bhumsuk Keam, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 6, 2021
Implication of CD69<sup>+</sup> CD103<sup>+</sup> tissue-resident-like CD8<sup>+</sup> T cells as a potential immunotherapeutic target for cholangiocarcinomaHyung-Don Kim, Seongju Jeong, Seongyeol Park, et al.
Pageof 5